Results: Of 112 hospitalized cancer elderly patients with high VTE risk, 84/112 patients (75%) were not at high risk bleeding (IMPROVE <7); in which 39 (46.4%) patients received and 45 (53.6%) not receive anticoagulation therapy for VTE prophylaxis.